Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.

about

Novel oral anticoagulants in non-valvular atrial fibrillation.

P2860

Q34666804-AECD05B6-53CF-4A75-B12F-6A09875EFDD6

P2860

Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.

Item

http://www.wikidata.org/entity/Q38116784

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel oral anticoagulants and ...... ion and chronic heart failure.

@en

type

Item

label

Novel oral anticoagulants and ...... ion and chronic heart failure.

@en

prefLabel

Novel oral anticoagulants and ...... ion and chronic heart failure.

@en

P1476

Novel oral anticoagulants and ...... ion and chronic heart failure.

@en

P2093

A J Camm

http://www.w3.org/2001/XMLSchema#string

Christopher J Boos

http://www.w3.org/2001/XMLSchema#string

Michael Nam

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation

Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation

National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Dabigatran versus warfarin in patients with atrial fibrillation

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Validation of Clinical Classification Schemes for Predicting Stroke

P2888

s10741-013-9398-3

P304

391-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-013-9398-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23797696

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

anticoagulation

Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.

about

P2860

P2860

Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921